Sarah A. Solomon is a partner in the firm’s Technology and Life Sciences groups. She currently serves on the firm’s Executive Committee and as a Co-Chair of Women@Goodwin.
Sarah represents biotechnology, pharmaceutical and other life sciences companies in connection with their intellectual property, commercial, and M&A transactions. She regularly advises private and public companies on complex strategic collaboration and partnering transactions; research, development, manufacturing, and commercial relationships; and mergers and acquisitions. Sarah also counsels clients in connection with international transactions in North America, South America, Europe, and Asia.
